December 12, 2021
Indivumed appoints Dr. Stephan Schüller as CFO
Indivumed is pleased to announce that Dr. Stephan Schüller has joined Indivumed as Chief Financial Officer. With more than 30 years of experience as a business executive, professor, and board member, Dr. Schüller brings highly valuable knowledge and perspectives to Indivumed.
“It is a pleasure to support Indivumed in the current growth phase,” said Dr. Schüller. “Indivumed has a unique opportunity to realize better cancer care by data- and AI-driven precision oncology and it is a great privilege for me that I am allowed to contribute from a financial perspective realizing the full value of this amazing company.”
A prominent financial leader, Dr. Schüller studied business economics at the Westfälische Wilhelms-Universität in Münster, Germany. Since 1992, Schüller has taught business politics of financial institutions at the University of Duisburg-Essen and the Mercator School of Management.
Prior to joining Indivumed, Dr. Schüller was the CEO of Bankhaus Lampe KG in Düsseldorf and Vereins-und Westbank AG in Hamburg, respectively. Dr. Schüller was also a board member for several financial institutions, including Vereins-und Westbank AG in Hamburg and HypoVereinsbank AG (formerly Bayrische Vereinsbank) in München.
“I am honored that Stephan Schüller has decided to join Indivumed. With him we could win a worldwide highly respected financial expert to support Indivumed in becoming the leading AI- and data-driven company for precision oncology.” said Dr. Hartmut Juhl, Founder and CEO of Indivumed.